Health Policy Advocacy & Market Access

Bernstein Health is a strategy consultancy firm for market access and health policy advocacy. Our team of experienced experts interweaves these two strands and knows the relevant issues, procedures and actors in detail. We offer customized solutions and create synergies for our clients through our integrated consulting approach.

A holistic approach that creates meaningful synergies

The integration of political lobbying and market access creates impact. We develop holistic strategies for pharmaceutical companies, care providers and other actors in the healthcare system at the interface between politics and the public, based on data, facts and findings.

Many years of experience and a resilient network

Rooted in Berlin and with excellent networks in Brussels and the federal states: our team has many years of experience in advising companies for whom legislation and communication are critical to success – in regulatory decisions, marketing approval or reimbursement of costs.

Integrated consulting to achieve strategic goals

Bernstein Health helps companies in the healthcare industry to successfully introduce their products in Germany. We follow health policy developments and advocate our clients’ interests in the political process. We offer effective, tailor-made services to implement the strategic goals of our clients.

We bring market access and political advocacy together

The interactions between health policy decisions and the procedures for introducing new medical products into the healthcare market are becoming increasingly important. Joining both together is essential for appropriate and patient-oriented care.

The healthcare system is changing

The healthcare system and the way in which health policy is made are undergoing lasting change. Political decision-makers and opinion leaders are increasingly thinking in terms of larger health policy guidelines. The healthcare system is becoming more political and the opportunities to help shape decision-making processes are becoming more diverse.

Covid-19 reveals the strengths and weaknesses of the system.

The pandemic is placing unprecedented demands on the healthcare system and the (health-related) political stakeholders. Covid-19 is challenging the established system. Politicians must find a way to strengthen resilience against this and upcoming pandemics while remaining efficient.

Personalized therapies require a new framework

ATMPs, personalized therapies and pharmaceuticals offer unprecedented opportunities for treating illnesses by allowing them to be tailored to individual patients. These new opportunities are also associated with new health-economic and regulatory challenges.

Cost pressure and efficiency requirements are increasing considerably.

Payers are being forced to control and limit their expenditure, and not only because of the Covid-19 crisis. The high prices for advanced therapies place a major burden on health insurance companies and are leading to financial and ethical debates. Proving the efficacy of a therapy is becoming even more important.

Market access & strategy

We identify barriers to market access and use proven methods to overcome them. We develop strategies to overcome challenges for patient access to therapies.

Price negotiations & reimbursement

We develop solutions for price negotiations in the self-management system. We analyze evidence requirements to accompany our clients every step of the way.

Political advocacy

We are conversant with German health policy and decision-making process-es. We are connected to relevant stakeholders in Berlin, Brussels and the federal states. We are actively involved in shaping health policy debates.

Corporate communications

We generate media attention for our clients’ issues. We position them in the media outlets that are relevant to them. We supplement political strategies with targeted media coverage.

Two experienced consulting firms join forces

Bernstein Health is a 50/50 joint venture that brings together a wide range of expertise. We create modern health policy frameworks and pave the way for innovative therapies and medical services.


Sven Rawe

Co-Founder, Bernstein Group

Sven Rawe is an experienced entrepreneur and angel investor who has successfully co-founded other companies besides the Bernstein Group. He has worked as a communications consultant and advisor on political and regulatory issues in Germany and internationally for 25 years.

Julia Spitze

Co-Founder, Bernstein Group

Julia Spitze manages the business of the Bernstein Group, which, in addition to political advocacy, also offers corporate communications and data-driven political analyses. She has been advising companies and associations on their positioning in the political arena and developing political strategies for more than 15 years.

(DE) Johannes Heuser


(DE) Johannes Heuser verantwortet als Director den Ausbau der Bernstein Health. Er ist Public Affairs- und Kommunikationsexperte mit langjähriger Erfahrung im Gesundheitssektor. Vor seiner Zeit bei der Bernstein Health baute er die Gesundheits-Practice einer strategischen Kommunikationsberatung auf. Er berät Unternehmen bei der Marktzulassung, der strategischen Positionierung und bei der Vertretung politischer Interessen im Gesundheitssektor.  

+49 (0) 172 316 533 2

Dr. Philipp Mauch

Co-Founder, PIVOT Regulatory

Philipp Mauch focuses on the combination of economic, scientific, legal and political aspects to create an integrated, evidence-based regulatory strategy. Prior to founding Pivot, he worked at Sandoz, Shire and Philip Morris in the areas of health policy, market access and product regulation.

Alexander Hinz

Co-Founder, PIVOT Regulatory

Alexander Hinz’s main focus is on regulatory analytics. This concerns the analysis and assessment of regulation on consumers, companies and markets. Prior to founding Pivot, he worked at PricewaterhouseCoopers, Philip Morris International and Bayer MaterialScience in the areas of product regulation, product safety and EHS-related risk management.


Current standpoints, assessments, and debate contributions from the Bernstein Health team.


Behind the scenes

Für mehr Perspektiven finden Sie uns auch auf LinkedIn


You share our passion for health policy and market access? Become part of our team!



Bernstein Health GmbH
Neustädtische Kirchstraße 6
10117 Berlin

+49 30 275 723 – 0



For Bernstein Group, Analytics, Public Policy, Communications and Health:

Bernstein Communications GmbH
Neustädtische Kirchstraße 6
D-10117 Berlin
Phone: +49 30 275 723 -0
Management: Sven Rawe, Ralf Kunkel
AG Charlottenburg (Berlin)
HRB 182680 B
VAT Number: DE301067174